CONJUNCTIVAL PYOGENIC GRANULOMA ASSOCIATED WITH INTRAVITREAL BEVACIZUMAB INJECTION

    loading  Checking for direct PDF access through Ovid

Abstract

Purpose:

To report a case of conjunctival pyogenic granuloma after intravitreal injection of anti–vascular endothelial growth factor, bevacizumab.

Methods:

A 52-year-old patient after 3 intravitreal bevacizumab injections was found to have a vascular conjunctival nodule at the injection site. A pathologic analysis of the vascular conjunctival nodule was performed after surgical excision.

Results:

The pathologic analysis revealed a conjunctival pyogenic granuloma.

Conclusion:

Conjunctival pyogenic granuloma can complicate an otherwise uneventful intravitreal anti–vascular endothelial growth factor injection.

Related Topics

    loading  Loading Related Articles